CRISPR/Cas9-based development of RNAi rat models for drug discovery

被引：0
|
作者：
Premsrirut, Prem K. [1 ]
Wang, Chia-Lin [1 ]
Yang, Yu-Ting [1 ]
Dow, Lukas E. [2 ]
Zuber, Johannes [3 ]
Lowe, Scott W. [4 ]
机构：
[1] Mirimus Inc, Brooklyn, NY USA
[2] Weill Cornell Med Coll, New York, NY USA
[3] Res Inst Mol Pathol, Vienna, Austria
[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-5106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5106
引用
收藏
页数：2
相关论文
共 50 条
  • [1] RNAi and CRISPR/Cas9-based in vivo models for drug discovery
    Premsrirut, Prem K.
    Fellmann, Christof
    CANCER RESEARCH, 2015, 75
  • [2] RNAi and CRISPR/Cas9-based in vivo models for drug discovery.
    Premsrirut, Prem K.
    Wang, Chia-Lin
    Yang, Yu-Ting
    Pelossof, Rafii
    Leslie, Christina
    Fellmann, Christof
    Dow, Lukas
    Zuber, Johannes
    Lowe, Scott
    CANCER RESEARCH, 2018, 78 (10) : 73 - 73
  • [3] RNAi and CRISPR/Cas9 Based In Vivo Models for Drug Discovery
    Premsrirut, Prem
    Wang, Chia-Lin
    Yang, Yu-ting
    Fellmann, Christof
    Dow, Lukas
    Zuber, Johannes
    Lowe, Scott
    Pesic, Marina
    Wolter, Katharina
    Zender, Lars
    BLOOD, 2017, 130
  • [4] RNAi and CRISPR/Cas9 based in vivo models for drug discovery
    Premsrirut, Prem
    Martin, Gregory
    Dow, Lukas
    Kim, Sang Yong
    Zuber, Johannes
    Lowe, Scott
    Hannon, Greg
    TRANSGENIC RESEARCH, 2016, 25 (02) : 218 - 218
  • [5] RNAi and CRISPR/Cas9 based in vivo models for drug discovery
    Premsrirut, Prem K.
    Martin, Gregory
    Dow, Lukas
    Kim, Sang Yong
    Zuber, Johannes
    Lowe, Scott
    Hannon, Greg
    CANCER RESEARCH, 2016, 76
  • [6] RNAi and CRISPR/Cas9 based in vivo models for drug discovery
    Premsrirut, P.
    Martin, G.
    Dow, L.
    Kim, S. Y.
    Zuber, J.
    Hannon, G.
    Lowe, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S208 - S208
  • [7] Increasing the efficiency of CRISPR/Cas9-based gene editing by suppressing RNAi in plants
    Xiaoyan Wang
    Jiayun Lu
    Kangwen Lao
    Suikang Wang
    Xiaowei Mo
    Xintong Xu
    Xuemei Chen
    Beixin Mo
    Science China(Life Sciences), 2019, (07) : 982 - 984
  • [8] Increasing the efficiency of CRISPR/Cas9-based gene editing by suppressing RNAi in plants
    Xiaoyan Wang
    Jiayun Lu
    Kangwen Lao
    Suikang Wang
    Xiaowei Mo
    Xintong Xu
    Xuemei Chen
    Beixin Mo
    Science China Life Sciences, 2019, 62 : 982 - 984
  • [9] Increasing the efficiency of CRISPR/Cas9-based gene editing by suppressing RNAi in plants
    Wang, Xiaoyan
    Lu, Jiayun
    Lao, Kangwen
    Wang, Suikang
    Mo, Xiaowei
    Xu, Xintong
    Chen, Xuemei
    Mo, Beixin
    SCIENCE CHINA-LIFE SCIENCES, 2019, 62 (07) : 982 - 984
  • [10] Increasing the efficiency of CRISPR/Cas9-based gene editing by suppressing RNAi in plants
    Xiaoyan Wang
    Jiayun Lu
    Kangwen Lao
    Suikang Wang
    Xiaowei Mo
    Xintong Xu
    Xuemei Chen
    Beixin Mo
    Science China(Life Sciences), 2019, 62 (07) : 982 - 984
12345